MOH:NYSE
Molina Healthcare Inc
$196.93
arrow_upward
+0.60%(+1.17) 1D
Oct 9, 4:00:04 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MOH...
Open
$197.69
High
$203.67
Low
$193.32
Mkt. cap
10.28B
Avg. vol.
644.31K
Volume
0.00
52-wk high
$244.89
52-wk low
$121.06
EPS
-$0.21
Beta
0.78
Shares outstanding
52.20M
No. of employees
19K
Open
$197.69
High
$203.67
Low
$193.32
Mkt. cap
10.28B
Avg. vol.
644.31K
Volume
0.00
52-wk high
$244.89
52-wk low
$121.06
EPS
-$0.21
Beta
0.78
Shares outstanding
52.20M
No. of employees
19K
News stories
From web sources and news partners
Simply Wall Street
·
13 hours ago
Molina Healthcare (MOH) Stock May Look Reasonable On Its Sales Base
Investing.com
·
2 days ago
Cantor Fitzgerald reiterates Molina Healthcare stock rating at Neutral
Profile
Molina Healthcare, Inc. is an American managed care company headquartered in Long Beach, California. The company provides health insurance to individuals through government programs such as Medicaid and Medicare. Wikipedia
About Molina Healthcare Inc
CEOJoseph M. Zubretsky
Employees19K
Founded1980
HeadquartersLong Beach, California, United States
SectorHealth care provider
Websitemolinahealthcare.com
Analyst ratings
Based on 15 analysts giving stock ratings to MOH in the past 3 months
Hold
Buy
3
Hold
11
Sell
1
12-month forecast
Based on 15 Wall Street analysts offering 12 month price targets for MOH in the last 3 months.
Highest
Current $196.93
$266.00 (+35.07%)
Average
$213.69 (+8.51%)
Lowest
$156.00 (-20.78%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Ben Hendrix RBC Capital | Hold | Maintained | $218.00 | +10.7% | 10/07/2026 |
Lance Wilkes Bernstein | Buy | Maintained | $266.00 | +35.1% | 10/05/2026 |
Stephen Baxter Wells Fargo | Hold | Maintained | $220.00 | +11.7% | 09/15/2026 |
John Stansel J.P. Morgan | Hold | Maintained | $220.00 | +11.7% | 07/28/2026 |
David S Macdonald Truist Financial | Hold | Maintained | $225.00 | +14.3% | 07/28/2026 |
Ryan Langston TD Cowen | Hold | Reiterated | $200.00 | +1.6% | 07/27/2026 |
A.J. Rice UBS | Hold | Maintained | $202.00 | +2.6% | 07/24/2026 |
Michael Ha Robert W. Baird | Hold | Reiterated | - | - | 07/24/2026 |
Jason Cassorla Guggenheim | Hold | Maintained | - | - | 07/23/2026 |
Andrew Mok CFA Barclays | Sell | Maintained | $180.00 | -8.6% | 07/24/2026 |
Scott Fidel Goldman Sachs | Hold | Maintained | $156.00 | -20.8% | 07/23/2026 |
Kevin Fischbeck Bank of America Securities | Buy | Maintained | $260.00 | +32% | 07/23/2026 |
Sarah James Cantor Fitzgerald | Hold | Maintained | $209.00 | +6.1% | 07/23/2026 |
Erin Wright Morgan Stanley | Hold | Reiterated | $167.00 | -15.2% | 07/24/2026 |
Ann Hynes Mizuho Securities | Buy | Maintained | $255.00 | +29.5% | 07/13/2026 |
Unknown Analyst Bernstein | Buy | Maintained | $208.00 | +5.6% | 05/27/2026 |
George Hill Deutsche Bank | Hold | Maintained | $129.00 | -34.5% | 04/24/2026 |
Justin Lake Wolfe Research | Hold | Maintained | - | - | 04/22/2026 |
David Windley Jefferies | Hold | Maintained | $139.00 | -29.4% | 04/20/2026 |
Next call in 10 days
Thu, Oct 22, 2:00 PM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $0.79
Revenue / Est. (USD)
- / 10.86B
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 10.97B | 10.84B | 10.29B | 10.37B |
Cost of goods sold | 10.04B | 10.14B | 9.27B | 9.44B |
Cost of revenue | 10.04B | 10.14B | 9.27B | 9.44B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 729.00M | 795.00M | 779.00M | 724.00M |
Operating expense | 790.00M | 863.00M | 846.00M | 784.00M |
Total operating expenses | 10.83B | 11.00B | 10.12B | 10.22B |
Operating income | 137.00M | -162.00M | 176.00M | 145.00M |
Other non operating income | - | - | - | - |
EBT including unusual items | 88.00M | -214.00M | 29.00M | 91.00M |
EBT excluding unusual items | 88.00M | -214.00M | 122.00M | 91.00M |
Income tax expense | 9.00M | -54.00M | 15.00M | 31.00M |
Effective tax rate | 10.23% | 25.23% | 51.72% | 34.07% |
Other operating expenses | 16.00M | 24.00M | 28.00M | 20.00M |
Net income | 79.00M | -160.00M | 14.00M | 60.00M |
Net profit margin | 0.72% | -1.48% | 0.14% | 0.58% |
Earnings per share | 1.84 | -2.75 | 2.35 | 1.51 |
Interest and investment income | - | - | - | - |
Interest expense | -49.00M | -52.00M | -54.00M | -54.00M |
Net interest expenses | -49.00M | -52.00M | -54.00M | -54.00M |
Depreciation and amortization charges | 45.00M | 44.00M | 39.00M | 40.00M |
EBITDA | 182.00M | -118.00M | 215.00M | 185.00M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1